All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: A favorable effect on vessel remodeling

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 1, 2000, Pages 89-95

  Wiegman, Peter J ^a   Barry, William L ^a   McPherson, John A ^a   McNamara, Coleen A ^a   Gimple, Lawrence W ^a   Sanders, John M ^a   Bishop, Gregory G ^a   Powers, Eric R ^a   Ragosta, Michael ^a   Owens, Gary K ^a   Sarembock, Ian J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angioplasty; Remodeling; Restenosis; Retinoic acid; Smooth muscle cells

Indexed keywords

PLACEBO; RETINOIC ACID;

ANGIOPLASTY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0033964461     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.1.89     Document Type: Article

References (39)

1. Mata LA, Bosch X, David PR, Rapold HJ, Corcos T, Bourassa MG. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol. 1985;6:1239-1244.
2. Holmes DR Jr, Vliestra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, van Raden MJ, Mock MB. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the NLHBI. Am J Cardiol. 1984;53(suppl):77C-81C.
3. Leimgruber PP, Roubin GS, Hollman J, Costsonis GA, Meier B, Douglas JS, King SB, Gruentzig AR. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 1986;73: 710-717.
4. Liu M, Roubin GS, King SB III. Restenosis after coronary angioplasty: potential biological determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
5. Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol. 1987;60: 20B-28B.
6. Chesebro JH, Lam JYT, Badimon L, Fuster V. Restenosis after arterial angioplasty: a hemorheologic response to injury. Am J Cardiol. 1987;60: 10B-16B.
7. Blank RS, Swartz EA, Thompson MM, Onson EN, Owens GK. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ Res. 1995; 76:742-748.
8. Haller H, Lindschau C, Quass P, Distler A, Luft FC. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C. Circ Res. 1995;76:21-29.
9. Hayashi A, Suzuki T, Tajima S. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells. J Biochem. 1995;117:132-136.
10. Mori Y, Hatamochi A, Takeda K, Ueki H. Effects of tretinoin tocoferil on gene expression of the extracellular matrix components in human dermal fibroblasts in vitro. J Dermatol Sci. 1994;8:233-238.
11. Shigematsu T, Tajima S. Modulation of collagen synthesis and cell proliferation by retinoids in human skin fibroblasts. J Dermatol Sci. 1995;9:142-145.
12. Bigg HF, Cawston TE. All-trans-retinoic acid interacts synergistically with basic fibroblast growth factor and epidermal growth factor to stimulate the production of tissue inhibitor of metalloproteinases from fibroblasts. Arch Biochem Biophys. 1995;319:74-83.
13. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR. The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer. 1991;67:1556-1560.
14. Zouboulis CC, Krieter A, Gollnick H, Mischke D, Orfanos CE. Progressive differentiation of human sebocytes in vitro is characterized by increasing cell size and altering antigen expression and is regulated by culture duration and retinoids. Exp Dermatol. 1994;3:151-160.
15. Mehta K, McQueen T, Tucker S, Pandita R, Aggarwal BB. Inhibition by all-trans retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukoc Biol. 1994;55:336-342.
16. Hirokawa K, O'Shaughnessy KM, Ramrakha P, Wilkins MR. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids. Br J Pharmacol. 1994;113:1448-1454.
17. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood. 1992;80:2556-2562.
18. Barstad RM, Hamers MJ, Stephens RW, Sakariassen KS. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation. Blood. 1995;86:212-218.
19. Miano JM, Topouzis S, Majesky MW, Olson EN. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation. 1996;93:1886-1895.
20. Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P. Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood. 1992;79:1916-1919.
21. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Sheperd L, Willman C, Bloomfield CD, Rowe JM, Wiemik PH. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028.
22. Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukemia: biology and treatment. Semin Oncol. 1997;24:92-102.
23. Miano JM, Kelly LA, Artacho CA, Nuckolls RA, Piantedosi R, Blaner WS. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation. 1998;98:1219-1227.
24. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 1991;84:232-243.
25. Kritchevsky D, Tepper SA, Kim HK, Story JA, Vesselinovitch D, Wissler RW. Experimental atherosclerosis in rabbits fed cholesterol-free diets: comparison of peanut, corn, butter, and coconut oils. Exp Mol Pathol. 1976;24:375-391.
26. Collins MD, Tzimas G, Burgin H, Hummler H, Nau H. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit. Toxicol Appl Pharmacol. 1995;130:9-18.
27. Serruys PW, Herman J-P, Simon R, Rutsch W, Bode C, Laarman G-J, Van Dijk R, Van Den Bos A, Umans VA, Fox KA, Close P, Deckers JW. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty: Helvetica Investigators. N Engl J Med. 1995;333:757-763.
28. Bittl JA, Strony J, Brinker JA, Ahmed WH, Meckel CR, Chaitman BR, Maraganore J, Deutsch E, Adelman B. Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina: Hirulog Angioplasty Study Investigators. N Engl J Med. 1995;333:764-769.
29. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988;318:1714-1719.
30. Ellis SG, Roubin GS, Wilentz J, Douglas JSJ, King SBI. Effect of 18-to-24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
31. Pepine CJ, Hirshfeld JW, Macdonald RG, Henderson MA, Bass TA, Goldberg S, Savage MP, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Jugo R. A controlled trial of corticosteroids to prevent restenosis following coronary angioplasty: M-HEART Group. Circulation. 1988;81:1753-1761.
32. MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty?: results of the MERCATOR Study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation. 1992;86:100-110.
33. Di Mario CD, Gil R, Camenzind E, Ozaki Y, Birgelen CV, Umans V, Jaegere PD, Feyter PD, Roelandt J, Serruys P. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol. 1995;75:772-777.
34. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong SC, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
35. Kuntz RE, Gibson CM, Nobuyoshi M. Generalized model of restenosis after conventional angioplasty, stenting, and directional atherectomy. J Am Coll Cardiol. 1993;21:15-25.
36. Côté G, Tardif J-C, Lespérance J, Lambert J, Bourassa M, Bonan R, Gosselin G, Joyal M, Tanguay J-F, Nattel S, Gallo R, Crépeau J. Effects of probucol on vascular remodeling after coronary angioplasty. Circulation. 1999;99:30-34.
37. Ragosta M, Barry WL, Gimple LW, Gertz SD, McCoy KW, Stouffer GA, McNamara CA, Powers ER, Owens GK, Sarembock IJ. Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. Circulation. 1996;93:1194-1200.
38. Chen S, Gardner DG. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. J Clin Invest. 1998;102:653-662.
39. Archer SL. Diversity of phenotype and function of vascular smooth muscle cells. J Lab Clin Med. 1996;127:524-529.